Text Size

Adjunctive use of tafluprost with timolol provides additive effects for reduction of intraocular pressure in patients with glaucoma

Egorov E., Ropo A., Erichev V., Astakhov Y., Alekseev V., Takhchidi K., Zhaboedov G., Pasechnikova N., Kaljurand K., Palumaa K., Lagnovska G., Eugeny E.E.A., Staritskaya T.V., Evgen'evna E.T., Borisovna R.T., Sheremetyeva S.S., Oganezova J.G., Petrovich E.V., Vagizona Y.L., Sergueevich A.Y., Alekseevna D.G., Borisovna L.A., Kasimovna A.L., Victorovich P.A., Levko M., Martynova E., Kolotov A., Mironova E.M., Proshina O.I., Kozlova E.E., Sochinskaya V.K., Grishina T.S., Zhaboedov G.D., Petrenko O.V., Tymoshenkova O.V., Vitovska O.P., Kurilina O.I., Parkhomenko O.G., Pasechnokova N.V., Korol A.R., Klyuev G.O., Romodanova K.S., Nevska A., Padanevych E., Kaljurand K., Pastak M., Seljagina N., Palumaa K., Somma K., Laganovska G., Baumane K.


  • 2009
  • European Journal of Ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Russian State Medical University, 1 Ostrovitjanova Street, 117997 Moscow, Russian Federation; Santen Oy, Clinical Research, Helsinki, Finland

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.


Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group


Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022